Correspondence to editorial on “Genetically-modified, redirected T cells target hepatitis B surface antigen-positive hepatocytes and hepatocellular carcinoma lesions in a clinical setting” - Shunda Du; Karin Wisskirchen; Ke Zhang; Ulrike Protzer (Clinical and Molecular Hepatology)